Intellicell Biosciences Inc (fka SVFC)

[Shatner2]

inVentiv Health Strengthens Clinical Leadership Team

Burlington, Mass. – December 10, 2012 - inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, today announced organizational changes within its clinical group. Raymond Hill is joining the Company as Executive Vice President of Clinical, effective December 12, 2012, and will be responsible for leading the Company’s Clinical business segment, which includes Early Stage, Phase II-IV and Strategic Resourcing.

“We are very pleased to welcome a seasoned industry veteran like Ray to inVentiv and expect that his significant experience in both successfully growing pharmaceutical services businesses and leading productive teams will be an asset to our organization,” said Paul Meister, Chief Executive Officer at inVentiv.

Prior to joining inVentiv, Hill was CEO at Pharmaceutical Product Development, Inc., where he successfully oversaw the process of taking the company private. Before that, he was President at IMS Consulting Group, where he oversaw an aggressive strategy of organic and inorganic growth – building the business from $100M in 2004 to $500M in 2010. Prior to IMS, Hill held a series of other positions in pharmaceutical consulting. He earned a Bachelor’s Degree from Cornell University and a Master’s Degree from Duke University.


link